Osteosarcopenia, an Asymmetrical Overlap of Two Connected Syndromes: Data from the OsteoSys Study

Osteoporosis and sarcopenia are two chronic conditions, which widely affect older people and share common risk factors. We investigated the prevalence of low bone mineral density (BMD) and sarcopenia, including the overlap of both conditions (osteosarcopenia) in 572 older hospitalized patients (mean age 75.1 ± 10.8 years, 78% women) with known or suspected osteoporosis in this prospective observational multicenter study. Sarcopenia was assessed according to the revised definition of the European Working Group on Sarcopenia in Older People (EWGSOP2). Low BMD was defined according to the World Health Organization (WHO) recommendations as a T-score < −1.0. Osteosarcopenia was diagnosed when both low BMD and sarcopenia were present. Low BMD was prevalent in 76% and the prevalence of sarcopenia was 9%, with 90% of the sarcopenic patients showing the overlap of osteosarcopenia (8% of the entire population). Conversely, only few patients with low BMD demonstrated sarcopenia (11%). Osteosarcopenic patients were older and frailer and had lower BMI, fat, and muscle mass, handgrip strength, and T-score compared to nonosteosarcopenic patients. We conclude that osteosarcopenia is extremely common in sarcopenic subjects. Considering the increased risk of falls in patients with sarcopenia, they should always be evaluated for osteoporosis.

[1]  G. Duque Osteosarcopenia: A Geriatric Giant of the XXI Century , 2021, The journal of nutrition, health & aging.

[2]  N. Murphy,et al.  Prevalence of sarcopenia and associated factors in older adults attending a day hospital service in Ireland , 2021, European Geriatric Medicine.

[3]  S. Morishita,et al.  Related Factors and Clinical Outcomes of Osteosarcopenia: A Narrative Review , 2021, Nutrients.

[4]  L. Williams,et al.  Prevalence of Sarcopenia Employing Population-Specific Cut-Points: Cross-Sectional Data from the Geelong Osteoporosis Study, Australia , 2021, Journal of clinical medicine.

[5]  R. Kressig,et al.  Sarcopenia in hospitalized geriatric patients: insights into prevalence and associated parameters using new EWGSOP2 guidelines , 2020, European Journal of Clinical Nutrition.

[6]  N. Watts,et al.  AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS-2020 UPDATE. , 2020, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[7]  G. Duque,et al.  Osteosarcopenia: epidemiology, diagnosis, and treatment—facts and numbers , 2020, Journal of cachexia, sarcopenia and muscle.

[8]  V. Probst,et al.  The Joint Occurrence of Osteoporosis and Sarcopenia (Osteosarcopenia): Definitions and Characteristics. , 2020, Journal of the American Medical Directors Association.

[9]  P. Abete,et al.  Comparing EWGSOP2 and FNIH Sarcopenia Definitions: Agreement and Three-Year Survival Prognostic Value in Older Hospitalized Adults. The GLISTEN Study. , 2019, The journals of gerontology. Series A, Biological sciences and medical sciences.

[10]  B. Iglseder,et al.  Consequences of applying the new EWGSOP2 guideline instead of the former EWGSOP guideline for sarcopenia case finding in older patients. , 2019, Age and ageing.

[11]  C. Cooper,et al.  Sarcopenia: revised European consensus on definition and diagnosis , 2019, Age and ageing.

[12]  B. Iglseder,et al.  Sarcopenia and osteoporosis are interrelated in geriatric inpatients , 2019, Zeitschrift für Gerontologie und Geriatrie.

[13]  D. Volkert,et al.  Prevalence and overlap of sarcopenia, frailty, cachexia and malnutrition in older medical inpatients , 2019, BMC Geriatrics.

[14]  Andrea B. Maier,et al.  Sarcopenia and its association with falls and fractures in older adults: A systematic review and meta‐analysis , 2019, Journal of cachexia, sarcopenia and muscle.

[15]  W. Chau,et al.  The relationship between sarcopenia and fragility fracture—a systematic review , 2019, Osteoporosis International.

[16]  C. Meskers,et al.  Prevalence of sarcopenia in inpatients 70 years and older using different diagnostic criteria , 2018, Nursing open.

[17]  René Rizzoli,et al.  Sarcopenia: revised European consensus on definition and diagnosis , 2018, Age and ageing.

[18]  H. E. Andersen,et al.  Sarcopenia and osteoporosis in older people: a systematic review and meta-analysis , 2018, European Geriatric Medicine.

[19]  P. McNicholas,et al.  The prevalence of sarcopenia in community-dwelling older adults, an exploration of differences between studies and within definitions: a systematic review and meta-analyses , 2018, Age and ageing.

[20]  J. Reginster,et al.  Bone health assessment in older people with or without muscle health impairment , 2018, Osteoporosis International.

[21]  H. Hirschfeld,et al.  Osteosarcopenia: where bone, muscle, and fat collide , 2017, Osteoporosis International.

[22]  S. Brennan-Olsen,et al.  Musculoskeletal decline and mortality: prospective data from the Geelong Osteoporosis Study , 2016, Journal of cachexia, sarcopenia and muscle.

[23]  J. Morley,et al.  Sarcopenia Is Recognized as an Independent Condition by an International Classification of Disease, Tenth Revision, Clinical Modification (ICD-10-CM) Code. , 2016, Journal of the American Medical Directors Association.

[24]  T. Amaral,et al.  Sarcopenia among hospitalized patients - A cross-sectional study. , 2015, Clinical nutrition.

[25]  C. Cooper,et al.  Osteoporosis and sarcopenia in older age. , 2015, Bone.

[26]  J. Cauley,et al.  Risk of Nonspine Fractures in Older Adults with Sarcopenia, Low Bone Mass, or Both , 2015, Journal of the American Geriatrics Society.

[27]  L. Ferrucci,et al.  SARC‐F: a symptom score to predict persons with sarcopenia at risk for poor functional outcomes , 2015, Journal of cachexia, sarcopenia and muscle.

[28]  M. Montero‐Odasso,et al.  Phenotype of osteosarcopenia in older individuals with a history of falling. , 2015, Journal of the American Medical Directors Association.

[29]  Jeffrey R Stout,et al.  Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS) , 2014, Age and ageing.

[30]  R. Wirth,et al.  Prevalence of sarcopenia in geriatric hospitalized patients. , 2014, Journal of the American Medical Directors Association.

[31]  H. Kaji Interaction between Muscle and Bone , 2014, Journal of bone metabolism.

[32]  S. Gariballa,et al.  Sarcopenia: prevalence and prognostic significance in hospitalized patients. , 2013, Clinical nutrition.

[33]  S. Cummings,et al.  Standardising the descriptive epidemiology of osteoporosis: recommendations from the Epidemiology and Quality of Life Working Group of IOF , 2013, Osteoporosis International.

[34]  C. Cooper,et al.  Prevalence of sarcopenia in community-dwelling older people in the UK using the European Working Group on Sarcopenia in Older People (EWGSOP) definition: findings from the Hertfordshire Cohort Study (HCS) , 2013, Age and ageing.

[35]  J. Morley,et al.  A simple frailty questionnaire (FRAIL) predicts outcomes in middle aged African Americans , 2012, The journal of nutrition, health & aging.

[36]  N. Binkley,et al.  Beyond FRAX: it's time to consider "sarco-osteopenia". , 2009, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

[37]  P. F. Kauff Group , 2000, Elegant Design.

[38]  L. Ferrucci,et al.  A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. , 1994, Journal of gerontology.

[39]  R. Dziewas,et al.  Impact of Sarcopenia on One-Year Mortality Among Older Hospitalized Patients with Impaired Mobility , 2017, The Journal of Frailty & Aging.

[40]  Kozo Nakamura,et al.  Is osteoporosis a predictor for future sarcopenia or vice versa? Four-year observations between the second and third ROAD study surveys , 2016, Osteoporosis International.

[41]  M. Drey,et al.  Osteosarcopenia is more than sarcopenia and osteopenia alone , 2015, Aging Clinical and Experimental Research.

[42]  M. Di Monaco,et al.  Prevalence of sarcopenia and its association with osteoporosis in 313 older women following a hip fracture. , 2011, Archives of gerontology and geriatrics.

[43]  Claus Christiansen,et al.  Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. , 1994, World Health Organization technical report series.